Prevalence and characteristics of individuals with undiagnosed HIV infection in France: Evidence from a survey on hepatitis B and C seroprevalence

Journal of Acquired Immune Deficiency Syndromes

Volumn 60, Issue 4, 2012, Pages

  Cazein, Françoise ^a   Barin, Francis ^b   Le Strat, Yann ^a   Pillonel, Josiane ^a   Le Vu, Stephane ^a   Lot, Florence ^a   Thierry, Damien ^b   Meffre, Christine ^a   Semaille, Caroline ^a  

^a INSTITUT DE VEILLE SANITAIRE   (France)

^b UNIVERSITÉ DE TOURS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; FEMALE; FRANCE; HEALTH SURVEY; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROPREVALENCE; SEX RATIO; SEXUAL ORIENTATION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ETHNIC GROUPS; FEMALE; FRANCE; GEOGRAPHY; HEPATITIS B; HEPATITIS C; HIV ANTIBODIES; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES; SEX DISTRIBUTION; SEXUAL BEHAVIOR; YOUNG ADULT;

EID: 84864257461     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318256b3fd     Document Type: Letter

References (15)

1. Campsmith ML, Rhodes PH, Hall HI, et al. Undiagnosed HIV prevalence among adults and adolescents in the United States at the end of 2006. J Acquir Immune Defic Syndr. 2010;53:619-624.
2. Health Protection Agency. Number of people living with HIV. In: Health Protection Agency, ed. HIV in the United Kingdom: 2011 Report. London, United Kingdom: Health Protection Services; 2011:5.
3. Costagliola D. Epidémiologie de l'infection à VIH. In: Yeni P, ed. Prise en charge médicale des personnes infectées par le VIH. Recommandations du Groupe d'Experts. Paris, France: La documentation française; 2010:24-33.
4. Working Group on Estimation of HIV Prevalence in Europe. HIV in hiding: methods and data requirements for the estimation of the number of people living with undiagnosed HIV. AIDS. 2011;25:1017-1023.
5. Nicoll A, Gill ON, Peckham C, et al. The Public health application of unlinked anonymous seroprevalence monitoring for HIV in the United Kingdom. Int J Epidemiol. 2000;29:1-10. (Pubitemid 30119701)
6. Meffre C, Le Strat Y, Delarocque-Astagneau E, et al. Prévalence des hépatites B et C en France en 2004 Internet. Saint-Maurice, France: Institut de Veille Sanitaire. 2007. 114. Available at: http://www.invs.sante.fr/ publications/2006/prevalence-b-c/index.html. Accessed April 20, 2012.
7. Meffre C, Le Strat Y, Delarocque-Astagneau E, et al. Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: social factors are important predictors after adjusting for known risk factors. J Med Virol. 2010;82:546-555.
8. Bajos N, Bozon M, eds. Enquête sur la sexualité en France: pratiques, genre et santé. Paris, France: Editions La Découverte; 2008.
9. Centers for Disease Control and Prevention (CDC). Vital signs: HIV prevention through care and treatment-United States. MMWR Morb Mortal Wkly Rep. 2011;60: 1618-1623.
10. Rice BD, Delpech VC, Chadborn TR, et al. Loss to follow-up among adults attending human immunodeficiency virus services in England, Wales, and Northern Ireland. Sex Transm Dis. 2011;38: 685-690.
11. Lanoy E, Lewden C, Lièvre L, et al. How does loss to follow-up influence cohort findings on HIV infection? A joint analysis of the French hospital database on HIV, Mortalité 2000 survey and death certificates. HIV Med. 2009;10: 236-245.
12. d'Almeida KW, Kierzek G, de Truchis P, et al. Modest public health impact of nontargeted immunodeficiency virus screening in 29 emergency departments. Arch Intern Med. 2011; 172:12-20.
13. Jauffret-Roustide M, Emmanuelli J, Quaglia M, et al. Impact of a harm-reduction policy on HIV and hepatitis C virus transmission among drug users: recent French data-the ANRS-Coquelicot Study. Subst Use Misuse. 2006;41:1603-1621. (Pubitemid 44470232)
14. Cazein F, Le Strat Y, Pillonel J, et al. Dépistage du VIH et découvertes de séropositivité, France, 2003-2010. Bull Epidémiol Hebd. 2011;43-44:446-454.
15. Le Vu S, Le Strat Y, Barin F, et al. Populationbased HIV-1 incidence in France, 2003-08: a modelling analysis. Lancet Infect Dis. 2010;10:682-687.